Registration Is Required.
Recent Development in Hereditary Cancer Screening and Pharmacogenomic Testing – Current U.S. Clinical Perspective
1st Seminar (7:00-7:40 pm)
Recent advancements in next generation sequencing (NGS) based multi-gene testing panels in hereditary cancer clinical diagnosis
- Speaker: Lily Servais, MS, LCGC
- Color Genomics, USA
2nd Seminar (7:40-8:20 pm)
Personalizing medication management - Insight into the clinical benefits of implementing pharmacogenomic testing into clinical practice
- Speaker: Ryan Gregg, Ph.D.
- OneOme, USA
1st Seminar Abstract:
- Approximately 10% of all cancers are associated with hereditary cancer syndromes. Current recommendations for testing are primarily based on family/personal history of cancer. Because of phenotypic variability, etc. some carriers may be missed.
- Clinical utility studies to date have largely focused on these high-risk populations, and thus, clinical utility in a broader population has yet to be defined.
- To address this, we validated a 30-gene test for 8-hereditary cancers that is offered through a low-cost, easy-access delivery model.
- We will report clinical test results from both the U.S. and Asian populations, and evaluate current recommendations provided by the U.S. National Comprehensive Cancer Network (NCCN)
2nd Seminar Abstract:
- Pharmacogenomics is the science underlying the impact of specific genetic variants on the metabolism and mechanism of action of different medications.
- Physicians can now gain insight into which medications may pose additional risk of toxicity, lack of efficacy, or side effects.
- In this seminar, we will -
- Highlight medications that are impacted by pharmacogenomic variants in cardiology, psychiatry, and oncology, with supporting clinical evidence.
- Present patient cases where pharmacogenomic testing may be beneficial in optimizing medication selection and dosing.
- Discuss the services available through OneOme’s unique provider web portal supporting pharmacists and physicians at point-of-prescription
- Reception: 6:30-7:00 pm
- 1st Seminar: 7:00 -7:40 pm
- 2nd Seminar: 7:40 -8:20 pm
- Q&A with panel discussions: From 8:20 pm until all questions addressed
- Refreshment with beverages served throughout the event